Vol. 12, Special Issue 8 (2023)

Author(s):
Dr. Pallavi Khajuria, Dr. Gurpreet Singh, Dr. Dawoud Aamir Nehru, Dr. Inder Pal Singh, Dr. Amit Challana and Dr. Anavil Bhardwaj

Abstract:
Niacin is frequently referred to as a ‘broad spectrum anti-hyperlipidemic drug’. Niacin has been reported to reduce total plasma cholesterol, triglyceride, VLDL, and LDL concentrations and increases HDL concentration. This makes niacin ideal for treating a wide variety of lipid disorders, including the metabolic syndrome, diabetes mellitus, isolated low high-density lipoprotein cholesterol, and hypertriglyceridemia.